FibroGen
FGEN
#9977
Rank
NZ$61.62 M
Marketcap
NZ$15.23
Share price
3.70%
Change (1 day)
-1.60%
Change (1 year)

Market capitalization of FibroGen (FGEN)

Market cap: NZ$61.62 Million

As of December 2025 FibroGen has a market cap of NZ$61.62 Million. This makes FibroGen the world's 9977th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of FibroGen from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$61.62 M-40.54%
2024NZ$0.10 B-24.81%
2023NZ$0.13 B-94.19%
2022NZ$2.37 B23.88%
2021NZ$1.91 B-59.09%
2020NZ$4.67 B-16.2%
2019NZ$5.58 B-5.29%
2018NZ$5.89 B7.44%
2017NZ$5.48 B181.15%
2016NZ$1.95 B-29.29%
2015NZ$2.75 B33.94%
2014NZ$2.06 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of FibroGen was reported to be:

NZ$59.42 Million
by Nasdaq info icon info icon
NZ$59.42 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Illumina
ILMN
NZ$35.81 B 58,014.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$18.87 B 30,537.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Accelerate Diagnostics
AXDX
NZ$1.48 M-97.59%๐Ÿ‡บ๐Ÿ‡ธ USA